Skip to main content
Journal cover image

GS-4997, an Inhibitor of Apoptosis Signal-Regulating Kinase (ASK1), Alone or in Combination with Simtuzumab for the Treatment of Nonalcoholic Steatohepatitis (NASH): A Randomized, Phase 2 Trial

Publication ,  Conference
Loomba, R; Lawitz, E; Mantry, PS; Jaya-kumar, S; Caldwell, SH; Arnold, H; Diehl, AM; Djedjos, CS; Jia, C; Myers, RP; Subramanian, M ...
Published in: HEPATOLOGY
December 1, 2016

Duke Scholars

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

December 1, 2016

Volume

64

Issue

6

Start / End Page

1119A / 1120A

Location

Boston, MA

Publisher

WILEY

Conference Name

67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Loomba, R., Lawitz, E., Mantry, P. S., Jaya-kumar, S., Caldwell, S. H., Arnold, H., … Charlton, M. R. (2016). GS-4997, an Inhibitor of Apoptosis Signal-Regulating Kinase (ASK1), Alone or in Combination with Simtuzumab for the Treatment of Nonalcoholic Steatohepatitis (NASH): A Randomized, Phase 2 Trial. In HEPATOLOGY (Vol. 64, pp. 1119A-1120A). Boston, MA: WILEY.
Loomba, Rohit, Eric Lawitz, Parvez S. Mantry, Saumya Jaya-kumar, Stephen H. Caldwell, Hays Arnold, Anna Mae Diehl, et al. “GS-4997, an Inhibitor of Apoptosis Signal-Regulating Kinase (ASK1), Alone or in Combination with Simtuzumab for the Treatment of Nonalcoholic Steatohepatitis (NASH): A Randomized, Phase 2 Trial.” In HEPATOLOGY, 64:1119A-1120A. WILEY, 2016.
Loomba R, Lawitz E, Mantry PS, Jaya-kumar S, Caldwell SH, Arnold H, Diehl AM, Djedjos CS, Jia C, Myers RP, Subramanian M, McHutchison JG, Goodman ZD, Afdhal NH, Charlton MR. GS-4997, an Inhibitor of Apoptosis Signal-Regulating Kinase (ASK1), Alone or in Combination with Simtuzumab for the Treatment of Nonalcoholic Steatohepatitis (NASH): A Randomized, Phase 2 Trial. HEPATOLOGY. WILEY; 2016. p. 1119A-1120A.
Journal cover image

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

December 1, 2016

Volume

64

Issue

6

Start / End Page

1119A / 1120A

Location

Boston, MA

Publisher

WILEY

Conference Name

67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics